ARTICLE | Company News
Elusys, Pfizer deal
January 8, 2007 8:00 AM UTC
The companies partnered to develop infectious disease therapeutics using Elusys' Heteropolymer (HP) Antibody technology, which chemically links together two antibodies. The deal includes Elusys' ETI-...